Vertex Pharmaceuticals Incorporated
VRTXNASDAQHealthcare● Active
$442.96
$-3.87(-0.87%)
Market Cap$112.4B
P/E Ratio—
52W High$507.92
52W Low$362.5
Vertex Pharmaceuticals Incorporated (VRTX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · VRTX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $6.61B | $6.12B | $11.22B | $10.78B | $7.52B |
| Net Receivables | $2.05B | $1.61B | $1.56B | $1.44B | $1.14B |
| Inventory | $1.69B | $1.21B | $0.74B | $0.46B | $0.35B |
| Total Current Assets | $11.20B | $9.60B | $14.14B | $13.23B | $9.56B |
| PP&E Net | $3.08B | $2.58B | $1.45B | $1.46B | $1.42B |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.00B |
| Intangible Assets | $0.42B | $0.83B | $0.84B | $0.60B | $0.40B |
| Total Assets | $26.14B | $22.53B | $22.73B | $18.15B | $13.43B |
| Liabilities | |||||
| Short-Term Debt | $0.08B | $0.09B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.46B | $0.41B | $0.36B | $0.30B | $0.20B |
| Total Current Liabilities | $3.86B | $3.56B | $3.55B | $2.74B | $2.14B |
| Long-Term Debt | $1.85B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $7.48B | $6.12B | $5.15B | $4.24B | $3.33B |
| Stockholders Equity | |||||
| Retained Earnings | $13.56B | $9.61B | $10.14B | $6.52B | $3.20B |
| Total Stockholders Equity | $18.67B | $16.41B | $17.58B | $13.91B | $10.10B |
| Total Liab & Equity(computed) | $26.14B | $22.53B | $22.73B | $18.15B | $13.43B |
| Debt Summary | |||||
| Total Debt | $3.88B | $1.75B | $0.81B | $0.90B | $0.97B |
| Net Debt | ($1.21B) | ($2.82B) | ($9.56B) | ($9.60B) | ($5.83B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Vertex Pharmaceuticals Incorporated data
About Vertex Pharmaceuticals Incorporated (VRTX) Balance Sheet
Vertex Pharmaceuticals Incorporated (VRTX) balance sheet shows total assets of $26.14B with cash of $6.61B. Total liabilities are $7.48B, total debt $3.88B, and stockholders equity $18.67B.
Frequently asked questions
VRTX · 4 questionsVertex Pharmaceuticals Incorporated has total debt of $3.88B with net debt of ($1.21B).
VRTX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10